Online gatherings are a bit like marmite, and it is fair to say they have the life science community divided. However, during uncertain times when face-to-face networking is not possible, there is the option to move online or cancel altogether.
The COVID-19 pandemic has thrown everything into flux. Communications and marketing have been no exception. With both staff and customers being largely remote, conferences and events disrupted, and a growing sense of product apathy among the public, companies have a serious communications hurdle to overcome. Many companies have seen this as an opportunity to update their websites and refocus their communications, both internal and external.
When delegates returned from the 38th annual JP Morgan Healthcare Conference in San Diego in mid-January this year, few can have imagined just how fast, and how dramatically, the biotech industry was about to change. Fewer than 10,000 cases of COVID-19 had been reported to the WHO by the end of that month, and few, other than infectious disease specialists, were taking very much notice of those reports.
That was the title of a panel discussion held during One Nucleus’ Life Science Leadership meeting at St Bartholomew’s Hospital in central London on 8 March this year supported by One Nucleus partners Cerba Research. It was, therefore, probably one of the last life sciences meetings to be held in the UK before we belatedly entered our coronavirus lockdown. Some delegates seemed rather nervous about mingling over the excellent buffet lunch, but there were few other signs of the tsunami of change that was about to engulf the industry.
The Science of Podcasts
So you’ve listened to a few podcasts on the daily commute (well, at least back when we all used to commute!) and thought we could do that in Life Sciences! Then you pause and think about the amount of work involved… How many episodes would we do? Who would be good on the show? How would we interview our guys across the pond?
For the long-term storage of biological samples at -80oC, historically there has only been one option: upright, mechanical compressor-based sample freezers. However nitrogen vapour freezers have arrived as an alternative, with no liquid nitrogen held within the freezer, these vary from the traditional cryogenic liquid nitrogen freezers.
ULT sample storage freezers are a vital part of many bio-banks, clinics and laboratories throughout the world. These units allow for medium to long-term storage of a wide array of biological sample such DNA, RNA, proteins or cell extracts.
Reduced Research & Development (R&D) productivity, as well as patent expiries and advances in technology, has led to significant changes for the pharmaceutical industry. Leading life sciences firms are not only being forced to look closely at the scale and cost of their property portfolios but also question whether they are located in the best environment to access innovation and talent. Real estate in the life science industry is moving from being an operational necessity to a source of competitive advantage.